Quadrant Capital »

Larimar Therapeutics shares owned by Quadrant Capital

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $55 14 3.93
2024-09-30 $2.4k 370 6.55

More positions owned by Quadrant Capital

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Schwab Strategic Tr Fundamental Us L (FNDX)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Amazon (AMZN)
Ishares Tr Core S&p Mcp Etf (IJH)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Procter & Gamble Company (PG)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Quadrant Capital

Top funds holding Larimar Therapeutics

Deerfield Management Company
RA Capital Management
Blue Owl Capital Holdings
Millennium Management
Opaleye Management
BlackRock
Rtw Investments
Vanguard Group
Caption Management
Logos Global Management
Adage Capital Partners GP
Alyeska Investment Group
Citadel Advisors
Woodline Partners
Goldman Sachs Group

View all funds holding Larimar Therapeutics